Home003060 • KRX
add
Aprogen Biologics Inc
Previous close
₩267.00
Day range
₩259.00 - ₩275.00
Year range
₩251.00 - ₩748.00
Market cap
52.38B KRW
Avg Volume
4.71M
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 20.36B | -7.64% |
Operating expense | 31.11B | 128.12% |
Net income | -36.05B | 39.92% |
Net profit margin | -177.02 | 34.95% |
Earnings per share | — | — |
EBITDA | -33.48B | -94.51% |
Effective tax rate | 3.28% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 51.63B | 34.75% |
Total assets | 586.99B | -0.68% |
Total liabilities | 309.43B | 45.75% |
Total equity | 277.57B | — |
Shares outstanding | 197.68M | — |
Price to book | 0.25 | — |
Return on assets | -16.07% | — |
Return on capital | -18.87% | — |
Cash Flow
Net change in cash
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -36.05B | 39.92% |
Cash from operations | -8.85B | -2.67% |
Cash from investing | -9.94B | 69.97% |
Cash from financing | 21.54B | -22.78% |
Net change in cash | 2.89B | 120.88% |
Free cash flow | 7.16B | 136.96% |
About
Founded
1960
Employees
390
